Clinical Trials Logo

Clinical Trial Summary

This study is a randomized controlled trial to determine whether i-scan can improve the detection of conventional adenomas and sessile serrated adenomas/polyps.


Clinical Trial Description

This is a randomized controlled trial comparing the use of i-scan (digital surface and contrast enhancement of the mucosa) versus standard high-definition white light for the detection of conventional adenomas and sessile serrated adenomas/polyps. Recent studies have indicated that colonoscopy is more effective in preventing cancer in the left side of the colon than the right side of the colon. The reasons for this difference may be partly biologic, in that a special group of polyps known as sessile serrated adenomas/polyps (SSA) are located primarily proximal to the splenic flexure. Sessile serrated adenomas/polyps share molecular features with a group of cancers that occur primarily in the proximal colon. These molecular features include CpG island methylator phenotype (CIMP) and microsatellite instability. These lesions are endoscopically subtle in that they are often flat, have the same color as the surrounding mucosa, and are hard to differentiate from normal mucosa. Recent studies have shown that image enhanced endoscopy can highlight the appearance of these lesions. This study will test whether i-scan increases the detection of conventional adenomas and sessile serrated adenomas/polyps in a randomized controlled trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02811419
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase N/A
Start date February 1, 2017
Completion date January 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT00208793 - Calcium and Vitamin D vs Markers of Adenomatous Polyps Phase 2
Completed NCT00399607 - Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention N/A
Completed NCT01661764 - Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention Phase 2